ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Clinical trials for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML) who have run out of standard treatments. The main goals are to find a safe dose and check for side effects. About 105 participant…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug cocktails tested in younger patients
Disease control Recruiting nowThis study is for adults aged 59 and younger with a high-risk form of acute myeloid leukemia (AML) that is harder to treat. It compares the standard chemotherapy with several newer drug combinations to see which works better at shrinking the cancer. About 335 people will take par…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New pill combo aims to keep childhood leukemia away after transplant
Disease control Recruiting nowThis early-stage trial tests the safety and best dose of an oral drug (ASTX727) plus a growth factor (filgrastim) in children with high-risk acute myeloid leukemia (AML) who have already had a stem cell transplant. The goal is to see if this maintenance therapy can help prevent t…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New hope for kids with tough leukemias: screening trial matches patients to targeted therapies
Knowledge-focused Recruiting nowThis study screens children and young adults (under 22) with leukemia that has returned or is difficult to treat. By analyzing their blood and bone marrow, doctors can identify specific genetic markers to match them with the most promising experimental treatments. The goal is to …
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
New screening tool aims to speed up matching cancer patients to the right clinical trials
Knowledge-focused Recruiting nowThis study is for adults with newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who have not yet received treatment. Researchers will test blood and bone marrow samples for specific biomarkers to see if participants can join a treatment trial that tar…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC